Rep. Justin Slaughter

Filed: 3/20/2024

 

 


 

 


 
10300HB4621ham001LRB103 36415 RLC 71009 a

1
AMENDMENT TO HOUSE BILL 4621

2    AMENDMENT NO. ______. Amend House Bill 4621 by replacing
3everything after the enacting clause with the following:
 
4    "Section 5. The Substance Use Disorder Act is amended by
5changing Section 5-23 as follows:
 
6    (20 ILCS 301/5-23)
7    Sec. 5-23. Drug Overdose Prevention Program.
8    (a) Reports.
9        (1) The Department may publish annually a report on
10    drug overdose trends statewide that reviews State death
11    rates from available data to ascertain changes in the
12    causes or rates of fatal and nonfatal drug overdose. The
13    report shall also provide information on interventions
14    that would be effective in reducing the rate of fatal or
15    nonfatal drug overdose and on the current substance use
16    disorder treatment capacity within the State. The report

 

 

10300HB4621ham001- 2 -LRB103 36415 RLC 71009 a

1    shall include an analysis of drug overdose information
2    reported to the Department of Public Health pursuant to
3    subsection (e) of Section 3-3013 of the Counties Code,
4    Section 6.14g of the Hospital Licensing Act, and
5    subsection (j) of Section 22-30 of the School Code.
6        (2) The report may include:
7            (A) Trends in drug overdose death rates.
8            (B) Trends in emergency room utilization related
9        to drug overdose and the cost impact of emergency room
10        utilization.
11            (C) Trends in utilization of pre-hospital and
12        emergency services and the cost impact of emergency
13        services utilization.
14            (D) Suggested improvements in data collection.
15            (E) A description of other interventions effective
16        in reducing the rate of fatal or nonfatal drug
17        overdose.
18            (F) A description of efforts undertaken to educate
19        the public about unused medication and about how to
20        properly dispose of unused medication, including the
21        number of registered collection receptacles in this
22        State, mail-back programs, and drug take-back events.
23            (G) An inventory of the State's substance use
24        disorder treatment capacity, including, but not
25        limited to:
26                (i) The number and type of licensed treatment

 

 

10300HB4621ham001- 3 -LRB103 36415 RLC 71009 a

1            programs in each geographic area of the State.
2                (ii) The availability of medication-assisted
3            treatment at each licensed program and which types
4            of medication-assisted treatment are available.
5                (iii) The number of recovery homes that accept
6            individuals using medication-assisted treatment in
7            their recovery.
8                (iv) The number of medical professionals
9            currently authorized to prescribe buprenorphine
10            and the number of individuals who fill
11            prescriptions for that medication at retail
12            pharmacies as prescribed.
13                (v) Any partnerships between programs licensed
14            by the Department and other providers of
15            medication-assisted treatment.
16                (vi) Any challenges in providing
17            medication-assisted treatment reported by programs
18            licensed by the Department and any potential
19            solutions.
20    (b) Programs; drug overdose prevention.
21        (1) The Department may establish a program to provide
22    for the production and publication, in electronic and
23    other formats, of drug overdose prevention, recognition,
24    and response literature. The Department may develop and
25    disseminate curricula for use by professionals,
26    organizations, individuals, or committees interested in

 

 

10300HB4621ham001- 4 -LRB103 36415 RLC 71009 a

1    the prevention of fatal and nonfatal drug overdose,
2    including, but not limited to, drug users, jail and prison
3    personnel, jail and prison inmates, drug treatment
4    professionals, emergency medical personnel, hospital
5    staff, families and associates of drug users, peace
6    officers, firefighters, public safety officers, needle
7    exchange program staff, and other persons. In addition to
8    information regarding drug overdose prevention,
9    recognition, and response, literature produced by the
10    Department shall stress that drug use remains illegal and
11    highly dangerous and that complete abstinence from illegal
12    drug use is the healthiest choice. The literature shall
13    provide information and resources for substance use
14    disorder treatment.
15        The Department may establish or authorize programs for
16    prescribing, dispensing, or distributing opioid
17    antagonists for the treatment of drug overdose. Such
18    programs may include the prescribing of opioid antagonists
19    for the treatment of drug overdose to a person who is not
20    at risk of opioid overdose but who, in the judgment of the
21    health care professional, may be in a position to assist
22    another individual during an opioid-related drug overdose
23    and who has received basic instruction on how to
24    administer an opioid antagonist.
25        (2) The Department may provide advice to State and
26    local officials on the growing drug overdose crisis,

 

 

10300HB4621ham001- 5 -LRB103 36415 RLC 71009 a

1    including the prevalence of drug overdose incidents,
2    programs promoting the disposal of unused prescription
3    drugs, trends in drug overdose incidents, and solutions to
4    the drug overdose crisis.
5        (3) The Department may support drug overdose
6    prevention, recognition, and response projects by
7    facilitating the acquisition of opioid antagonist
8    medication approved for opioid overdose reversal,
9    facilitating the acquisition of opioid antagonist
10    medication approved for opioid overdose reversal,
11    providing trainings in overdose prevention best practices,
12    connecting programs to medical resources, establishing a
13    statewide standing order for the acquisition of needed
14    medication, establishing learning collaboratives between
15    localities and programs, and assisting programs in
16    navigating any regulatory requirements for establishing or
17    expanding such programs.
18        (4) In supporting best practices in drug overdose
19    prevention programming, the Department may promote the
20    following programmatic elements:
21            (A) Training individuals who currently use drugs
22        in the administration of opioid antagonists approved
23        for the reversal of an opioid overdose.
24            (B) Directly distributing opioid antagonists
25        approved for the reversal of an opioid overdose rather
26        than providing prescriptions to be filled at a

 

 

10300HB4621ham001- 6 -LRB103 36415 RLC 71009 a

1        pharmacy.
2            (C) Conducting street and community outreach to
3        work directly with individuals who are using drugs.
4            (D) Employing community health workers or peer
5        recovery specialists who are familiar with the
6        communities served and can provide culturally
7        competent services.
8            (E) Collaborating with other community-based
9        organizations, substance use disorder treatment
10        centers, or other health care providers engaged in
11        treating individuals who are using drugs.
12            (F) Providing linkages for individuals to obtain
13        evidence-based substance use disorder treatment.
14            (G) Engaging individuals exiting jails or prisons
15        who are at a high risk of overdose.
16            (H) Providing education and training to
17        community-based organizations who work directly with
18        individuals who are using drugs and those individuals'
19        families and communities.
20            (I) Providing education and training on drug
21        overdose prevention and response to emergency
22        personnel and law enforcement.
23            (J) Informing communities of the important role
24        emergency personnel play in responding to accidental
25        overdose.
26            (K) Producing and distributing targeted mass media

 

 

10300HB4621ham001- 7 -LRB103 36415 RLC 71009 a

1        materials on drug overdose prevention and response,
2        the potential dangers of leaving unused prescription
3        drugs in the home, and the proper methods for
4        disposing of unused prescription drugs.
5    (c) Grants.
6        (1) The Department may award grants, in accordance
7    with this subsection, to create or support local drug
8    overdose prevention, recognition, and response projects.
9    Local health departments, correctional institutions,
10    hospitals, universities, community-based organizations,
11    and faith-based organizations may apply to the Department
12    for a grant under this subsection at the time and in the
13    manner the Department prescribes. Eligible grant
14    activities include, but are not limited to, purchasing and
15    distributing opioid antagonists, hiring peer recovery
16    specialists or other community members to conduct
17    community outreach, and hosting public health fairs or
18    events to distribute opioid antagonists, promote harm
19    reduction activities, and provide linkages to community
20    partners.
21        (2) In awarding grants, the Department shall consider
22    the overall rate of opioid overdose, the rate of increase
23    in opioid overdose, and racial disparities in opioid
24    overdose experienced by the communities to be served by
25    grantees. The Department shall encourage all grant
26    applicants to develop interventions that will be effective

 

 

10300HB4621ham001- 8 -LRB103 36415 RLC 71009 a

1    and viable in their local areas.
2        (3) (Blank).
3        (3.5) Any hospital licensed under the Hospital
4    Licensing Act or organized under the University of
5    Illinois Hospital Act shall be deemed to have met the
6    standards and requirements set forth in this Section to
7    enroll in the drug overdose prevention program upon
8    completion of the enrollment process except that proof of
9    a standing order and attestation of programmatic
10    requirements shall be waived for enrollment purposes.
11    Reporting mandated by enrollment shall be necessary to
12    carry out or attain eligibility for associated resources
13    under this Section for drug overdose prevention projects
14    operated on the licensed premises of the hospital and
15    operated by the hospital or its designated agent. The
16    Department shall streamline hospital enrollment for drug
17    overdose prevention programs by accepting such deemed
18    status under this Section in order to reduce barriers to
19    hospital participation in drug overdose prevention,
20    recognition, or response projects.
21        (4) In addition to moneys appropriated by the General
22    Assembly, the Department may seek grants from private
23    foundations, the federal government, and other sources to
24    fund the grants under this Section and to fund an
25    evaluation of the programs supported by the grants.
26    (d) Health care professional prescription of opioid

 

 

10300HB4621ham001- 9 -LRB103 36415 RLC 71009 a

1antagonists.
2        (1) A health care professional who, acting in good
3    faith, directly or by standing order, prescribes or
4    dispenses an opioid antagonist to: (a) a patient who, in
5    the judgment of the health care professional, is capable
6    of administering the drug in an emergency, or (b) a person
7    who is not at risk of opioid overdose but who, in the
8    judgment of the health care professional, may be in a
9    position to assist another individual during an
10    opioid-related drug overdose and who has received basic
11    instruction on how to administer an opioid antagonist
12    shall not, as a result of his or her acts or omissions, be
13    subject to: (i) any disciplinary or other adverse action
14    under the Medical Practice Act of 1987, the Physician
15    Assistant Practice Act of 1987, the Nurse Practice Act,
16    the Pharmacy Practice Act, or any other professional
17    licensing statute or (ii) any criminal liability, except
18    for willful and wanton misconduct.
19        (1.5) Notwithstanding any provision of or requirement
20    otherwise imposed by the Pharmacy Practice Act, the
21    Medical Practice Act of 1987, or any other law or rule,
22    including, but not limited to, any requirement related to
23    labeling, storage, or recordkeeping, a health care
24    professional or other person acting under the direction of
25    a health care professional may, directly or by standing
26    order, obtain, store, and dispense an opioid antagonist to

 

 

10300HB4621ham001- 10 -LRB103 36415 RLC 71009 a

1    a patient in a facility that includes, but is not limited
2    to, a hospital, a hospital affiliate, or a federally
3    qualified health center if the patient information
4    specified in paragraph (4) of this subsection is provided
5    to the patient. A person acting in accordance with this
6    paragraph shall not, as a result of his or her acts or
7    omissions, be subject to: (i) any disciplinary or other
8    adverse action under the Medical Practice Act of 1987, the
9    Physician Assistant Practice Act of 1987, the Nurse
10    Practice Act, the Pharmacy Practice Act, or any other
11    professional licensing statute; or (ii) any criminal
12    liability, except for willful and wanton misconduct.
13        (2) A person who is not otherwise licensed to
14    administer an opioid antagonist may in an emergency
15    administer without fee an opioid antagonist if the person
16    has received the patient information specified in
17    paragraph (4) of this subsection and believes in good
18    faith that another person is experiencing a drug overdose.
19    The person shall not, as a result of his or her acts or
20    omissions, be (i) liable for any violation of the Medical
21    Practice Act of 1987, the Physician Assistant Practice Act
22    of 1987, the Nurse Practice Act, the Pharmacy Practice
23    Act, or any other professional licensing statute, or (ii)
24    subject to any criminal prosecution or civil liability,
25    except for willful and wanton misconduct.
26        (3) A health care professional prescribing an opioid

 

 

10300HB4621ham001- 11 -LRB103 36415 RLC 71009 a

1    antagonist to a patient shall ensure that the patient
2    receives the patient information specified in paragraph
3    (4) of this subsection. Patient information may be
4    provided by the health care professional or a
5    community-based organization, substance use disorder
6    program, or other organization with which the health care
7    professional establishes a written agreement that includes
8    a description of how the organization will provide patient
9    information, how employees or volunteers providing
10    information will be trained, and standards for documenting
11    the provision of patient information to patients.
12    Provision of patient information shall be documented in
13    the patient's medical record or through similar means as
14    determined by agreement between the health care
15    professional and the organization. The Department, in
16    consultation with statewide organizations representing
17    physicians, pharmacists, advanced practice registered
18    nurses, physician assistants, substance use disorder
19    programs, and other interested groups, shall develop and
20    disseminate to health care professionals, community-based
21    organizations, substance use disorder programs, and other
22    organizations training materials in video, electronic, or
23    other formats to facilitate the provision of such patient
24    information.
25        (4) For the purposes of this subsection:
26        "Opioid antagonist" means a drug that binds to opioid

 

 

10300HB4621ham001- 12 -LRB103 36415 RLC 71009 a

1    receptors and blocks or inhibits the effect of opioids
2    acting on those receptors, including, but not limited to,
3    naloxone hydrochloride or any other similarly acting drug
4    approved by the U.S. Food and Drug Administration.
5        "Health care professional" means a physician licensed
6    to practice medicine in all its branches, a licensed
7    physician assistant with prescriptive authority, a
8    licensed advanced practice registered nurse with
9    prescriptive authority, an advanced practice registered
10    nurse or physician assistant who practices in a hospital,
11    hospital affiliate, or ambulatory surgical treatment
12    center and possesses appropriate clinical privileges in
13    accordance with the Nurse Practice Act, or a pharmacist
14    licensed to practice pharmacy under the Pharmacy Practice
15    Act.
16        "Patient" includes a person who is not at risk of
17    opioid overdose but who, in the judgment of the physician,
18    advanced practice registered nurse, or physician
19    assistant, may be in a position to assist another
20    individual during an overdose and who has received patient
21    information as required in paragraph (2) of this
22    subsection on the indications for and administration of an
23    opioid antagonist.
24        "Patient information" includes information provided to
25    the patient on drug overdose prevention and recognition;
26    how to perform rescue breathing and resuscitation; opioid

 

 

10300HB4621ham001- 13 -LRB103 36415 RLC 71009 a

1    antagonist dosage and administration; the importance of
2    calling 911; care for the overdose victim after
3    administration of the overdose antagonist; and other
4    issues as necessary.
5    (e) Drug overdose response policy.
6        (1) Every State and local government agency that
7    employs a law enforcement officer or fireman as those
8    terms are defined in the Line of Duty Compensation Act
9    must possess opioid antagonists and must establish a
10    policy to control the acquisition, storage,
11    transportation, and administration of such opioid
12    antagonists and to provide training in the administration
13    of opioid antagonists. A State or local government agency
14    that employs a probation officer, as defined in Section 9b
15    of the Probation and Probation Officers Act, or a fireman
16    as defined in the Line of Duty Compensation Act but does
17    not respond to emergency medical calls or provide medical
18    services shall be exempt from this subsection.
19        (2) Every publicly or privately owned ambulance,
20    special emergency medical services vehicle, non-transport
21    vehicle, or ambulance assist vehicle, as described in the
22    Emergency Medical Services (EMS) Systems Act, that
23    responds to requests for emergency services or transports
24    patients between hospitals in emergency situations must
25    possess opioid antagonists.
26        (3) Entities that are required under paragraphs (1)

 

 

10300HB4621ham001- 14 -LRB103 36415 RLC 71009 a

1    and (2) to possess opioid antagonists may also apply to
2    the Department for a grant to fund the acquisition of
3    opioid antagonists and training programs on the
4    administration of opioid antagonists.
5(Source: P.A. 101-356, eff. 8-9-19; 102-598, eff. 1-1-22.)
 
6    Section 10. The Pretrial Services Act is amended by
7changing Sections 1, 2, 3, 4, 5, 8, 9, 10, 12, 13, 14, 15, 22,
824, 30, and 33 and by adding Sections 0.02, 0.03, and 0.04 as
9follows:
 
10    (725 ILCS 185/0.02 new)
11    Sec. 0.02. Definitions. In this Act:
12    "Director" means the Director of the Office of Statewide
13Pretrial Services.
14    "Local pretrial services" means a pretrial services other
15than the Office who is providing pretrial services.
16    "Pretrial services" means any providing services to the
17circuit court as provided for in this Act, including the
18Office.
19    "Office" means the Office of Statewide Pretrial Services.
 
20    (725 ILCS 185/0.03 new)
21    Sec. 0.03. Office of Statewide Pretrial Services;
22establishment. There is established in the judicial branch of
23State government an office to be known as the Office of

 

 

10300HB4621ham001- 15 -LRB103 36415 RLC 71009 a

1Statewide Pretrial Services. This office shall be under the
2supervision and direction of a Director who shall be appointed
3by a vote of a majority of the Illinois Supreme Court Justices
4for a 4-year term and until a successor is appointed and
5qualified. The Director shall adopt rules, instructions, and
6orders, consistent with this Act, further defining the
7organization of this office and the duties of its employees.
8The Illinois Supreme Court shall approve or modify an
9operational budget submitted to it by the Office of Statewide
10Pretrial Services and set the number of employees each year.
 
11    (725 ILCS 185/0.04 new)
12    Sec. 0.04. Powers and duties.
13    (a) The Office shall provide pretrial services as provided
14in Section 7 to circuit courts or counties without existing
15pretrial services agencies.
16    (b) The Office shall develop, establish, adopt, and
17enforce uniform standards for pretrial services in this State.
18    (c) The Office may:
19        (1) hire and train State employed pretrial personnel;
20        (2) establish qualifications for pretrial officers as
21    to hiring, promotion, and training;
22        (3) establish a system of training and orientation for
23    local pretrial services agencies;
24        (4) Develop standards and approve employee
25    compensation schedules for local pretrial services

 

 

10300HB4621ham001- 16 -LRB103 36415 RLC 71009 a

1    agencies;
2        (5) establish a system of uniform forms;
3        (6) develop standards for a system of recordkeeping
4    for local pretrial services agencies;
5        (7) gather statistics and develop research for
6    planning of pretrial services in Illinois;
7        (8) establish a means of verifying the conditions for
8    reimbursement under this Act for local pretrial services
9    agencies and develop criteria for approved costs for
10    reimbursement;
11        (9) monitor and evaluate all pretrial programs
12    operated by local pretrial services agencies;
13        (10) review and approve annual plans submitted by
14    local pretrial services agencies; and
15        (11) establish such other standards and regulations
16    and do all acts necessary to carry out the intent and
17    purposes of this Act.
 
18    (725 ILCS 185/1)  (from Ch. 38, par. 301)
19    Sec. 1. The Chief Judge of each Each circuit court shall
20elect to receive pretrial services either through the Office
21or through a local pretrial services agency. The pretrial
22services agency has a duty establish a pretrial services
23agency to provide the court with accurate background data
24regarding the pretrial release of persons charged with
25felonies and effective supervision of compliance with the

 

 

10300HB4621ham001- 17 -LRB103 36415 RLC 71009 a

1terms and conditions imposed on release.
2(Source: P.A. 84-1449.)
 
3    (725 ILCS 185/2)  (from Ch. 38, par. 302)
4    Sec. 2. Local pretrial Pretrial services agencies may be
5independent divisions of the circuit courts accountable to the
6chief judge or his designee for program activities. The
7agencies shall be supervised by a program director appointed
8by the chief judge and removable for cause. The chief judge or
9his designee shall have the authority to hire, terminate or
10discipline local pretrial services agency personnel on
11recommendation of the program director.
12(Source: P.A. 84-1449.)
 
13    (725 ILCS 185/3)  (from Ch. 38, par. 303)
14    Sec. 3. Pretrial services shall be provided by the Office
15The functions of the pretrial services agency shall be
16assigned to the Department of Probation and Court Services or
17other arm of the court where the volume of criminal
18proceedings does not justify the establishment of a local
19pretrial services agency separate division.
20(Source: P.A. 84-1449.)
 
21    (725 ILCS 185/4)  (from Ch. 38, par. 304)
22    Sec. 4. All local pretrial services agency personnel shall
23be full-time employees supervised by the director and, except

 

 

10300HB4621ham001- 18 -LRB103 36415 RLC 71009 a

1for secretarial staff, subject to the hiring and training
2requirements established by the Office Supreme Court as
3provided in "An Act providing for a system of probation, for
4the appointment and compensation of probation officers, and
5authorizing the suspension of final judgment and the
6imposition of sentence upon persons found guilty of certain
7defined crimes and offenses, and legalizing their ultimate
8discharge without punishment", approved June 10, 1911, as
9amended.
10(Source: P.A. 84-1449.)
 
11    (725 ILCS 185/5)  (from Ch. 38, par. 305)
12    Sec. 5. The compensation for local pretrial services
13agency personnel shall be commensurate with salaries and other
14benefits accorded probation department employees.
15(Source: P.A. 84-1449.)
 
16    (725 ILCS 185/8)  (from Ch. 38, par. 308)
17    Sec. 8. In addition to the foregoing, local pretrial
18services agencies may with the approval of the chief judge
19provide one or more of the following services to the circuit
20court:
21    (a) Supervise compliance with the terms and conditions
22imposed by the courts for appeal bonds; and
23    (b) Assist in such other pretrial services activities as
24may be delegated to the agency by the court.

 

 

10300HB4621ham001- 19 -LRB103 36415 RLC 71009 a

1(Source: P.A. 84-1449.)
 
2    (725 ILCS 185/9)  (from Ch. 38, par. 309)
3    Sec. 9. Pretrial services agencies shall have standing
4court authority to interview and process all persons charged
5with non-capital felonies either before or after first
6appearance if the person is in custody. The chief judge and
7program director of the pretrial services agency may establish
8interviewing priorities where resources do not permit total
9coverage, but no other criteria shall be employed to exclude
10categories of offenses or offenders from program operations.
11(Source: P.A. 84-1449.)
 
12    (725 ILCS 185/10)  (from Ch. 38, par. 310)
13    Sec. 10. The chief judge and program director of the local
14pretrial services agency shall continuously assess the
15benefits of agency intervention before or after the first
16appearance of accused persons. In determining the best
17allocation of available resources, consideration shall be
18given to current release practices of first appearance judges
19in misdemeanor and lesser felony cases; the logistics of
20pre-first appearance intervention where decentralized
21detention facilities are utilized; the availability of
22verification resources for pre-first appearance intervention;
23and the ultimate goal of prompt and informed determinations of
24pretrial release conditions.

 

 

10300HB4621ham001- 20 -LRB103 36415 RLC 71009 a

1(Source: P.A. 84-1449.)
 
2    (725 ILCS 185/12)  (from Ch. 38, par. 312)
3    Sec. 12. Interviews shall be individually conducted by
4agency personnel in facilities or locations which assure an
5adequate opportunity for discussion, consistent with security
6needs.
7    The chief judge or his designee shall maintain a
8continuous liaison between the pretrial services agency
9director and the sheriff, or other affected law enforcement
10agencies, to assure that pretrial services interviewers have
11prompt access consistent with security and law enforcement
12needs to all prisoners after booking.
13(Source: P.A. 84-1449.)
 
14    (725 ILCS 185/13)  (from Ch. 38, par. 313)
15    Sec. 13. Information received from the arrested person as
16a result of the agency interview shall be recorded on uniform
17interview forms created by the Office.
18(Source: P.A. 84-1449.)
 
19    (725 ILCS 185/14)  (from Ch. 38, par. 314)
20    Sec. 14. The pretrial services agency shall, after
21interviewing arrestees, immediately verify and supplement the
22information required by the uniform interview form before
23submitting its report to the court. Minimum verification shall

 

 

10300HB4621ham001- 21 -LRB103 36415 RLC 71009 a

1include the interviewee's prior criminal record, residency,
2and employment circumstances. The chief judge or his designee
3shall assist the pretrial services agency program director in
4establishing and maintaining cooperation with the circuit
5clerk and law enforcement information systems to assure the
6prompt verification of prior criminal records.
7(Source: P.A. 84-1449.)
 
8    (725 ILCS 185/15)  (from Ch. 38, par. 315)
9    Sec. 15. Verified and supplemental information assembled
10by the pretrial services agency shall be recorded on a uniform
11reporting form established by the Office Supreme Court.
12(Source: P.A. 84-1449.)
 
13    (725 ILCS 185/22)  (from Ch. 38, par. 322)
14    Sec. 22. If so ordered by the court, the pretrial services
15agency shall prepare and submit for the court's approval and
16signature a uniform release order on the uniform form
17established by the Office Supreme Court in all cases where an
18interviewee may be released from custody under conditions
19contained in an agency report. Such conditions shall become
20part of the conditions of pretrial release. A copy of the
21uniform release order shall be provided to the defendant and
22defendant's attorney of record, and the prosecutor.
23(Source: P.A. 101-652, eff. 1-1-23.)
 

 

 

10300HB4621ham001- 22 -LRB103 36415 RLC 71009 a

1    (725 ILCS 185/24)  (from Ch. 38, par. 324)
2    Sec. 24. Where functions of the local pretrial services
3agency have been delegated to a probation department or other
4arm of the court under Section 3, their records shall be
5segregated from other records. Two years after the date of the
6first interview with a pretrial services agency
7representative, the defendant may apply to the chief circuit
8judge, or a judge designated by the chief circuit judge for
9these purposes, for an order expunging from the records of the
10pretrial services agency all files pertaining to the
11defendant.
12(Source: P.A. 84-1449.)
 
13    (725 ILCS 185/30)  (from Ch. 38, par. 330)
14    Sec. 30. Records and statistics shall be maintained by
15local pretrial services agencies of their operations and
16effect upon the criminal justice system, with monthly reports
17submitted to the circuit court and the Office Supreme Court on
18a uniform statistical form developed by the Supreme Court.
19(Source: P.A. 84-1449.)
 
20    (725 ILCS 185/33)  (from Ch. 38, par. 333)
21    Sec. 33. The Office Supreme Court shall pay from funds
22appropriated to it for this purpose 100% of all approved costs
23for pretrial services, including pretrial services officers,
24necessary support personnel, travel costs reasonably related

 

 

10300HB4621ham001- 23 -LRB103 36415 RLC 71009 a

1to the delivery of pretrial services, space costs, equipment,
2telecommunications, postage, commodities, printing and
3contractual services. Costs shall be reimbursed monthly, based
4on an annual a plan and budget approved by the Office Supreme
5Court. No department may be reimbursed for costs which exceed
6or are not provided for in the approved annual plan and budget.
7The Mandatory Arbitration Fund may be used to reimburse
8approved costs for pretrial services.
9(Source: P.A. 94-91, eff. 7-1-05; 94-839, eff. 6-6-06; 95-331,
10eff. 8-21-07; 95-707, eff. 1-11-08.)
 
11    (725 ILCS 185/1.5 rep.)
12    (725 ILCS 185/6 rep.)
13    Section 15. The Pretrial Services Act is amended by
14repealing Sections 1.5 and 6.
 
15    Section 99. Effective date. This Act takes effect upon
16becoming law, except that Sections 10 and 15 take effect on
17July 1, 2025.".